We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

86 hedge funds and large institutions have $148M invested in BioSpecifics Technologies Corp. in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 21

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

4% more funds holding

Funds holding: 83 → 86 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less capital invested

Capital invested by funds: $152M → $148M (-$4.9M)

Holders
86
Holders Change
+3
Holders Change %
+3.61%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
42
Reduced
21
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Allianz Asset Management
Allianz Asset Management
Germany
+$5.28M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.49M
3
BIT
BlackRock Institutional Trust
California
+$3.26M
4
BIM
Bogle Investment Management
Massachusetts
+$3M
5
RCMC
RK Capital Management (Colorado)
Colorado
+$2.46M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$7.42M
2
NC
Northpointe Capital
Michigan
-$2.42M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.51M
4
PAI
Palo Alto Investors
California
-$1.14M
5
Renaissance Technologies
Renaissance Technologies
New York
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
26
Royce & Associates
New York
$2.01M – – –
Charles Schwab
27
Charles Schwab
California
$1.95M +$146K +2,700 +6%
Morgan Stanley
28
Morgan Stanley
New York
$1.93M +$291K +5,393 +14%
Ameriprise
29
Ameriprise
Minnesota
$1.92M +$1.84M +34,010 +341%
AQR Capital Management
30
AQR Capital Management
Connecticut
$1.69M +$531K +9,845 +34%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$1.59M +$74K +1,371 +4%
PI
32
Putnam Investments
Massachusetts
$1.56M +$56.1K +1,040 +3%
Goldman Sachs
33
Goldman Sachs
New York
$1.48M +$2.64K +49 +0.1%
American Century Companies
34
American Century Companies
Missouri
$1.44M +$398K +7,367 +29%
Prudential Financial
35
Prudential Financial
New Jersey
$1.35M +$1.15M +21,400 +221%
PAI
36
Palo Alto Investors
California
$1.27M -$1.14M -21,179 -42%
BA
37
BlackRock Advisors
Delaware
$1.19M -$191K -3,543 -11%
First Manhattan
38
First Manhattan
New York
$1.17M +$1.3M +24,000 +833%
BCM
39
Bridgeway Capital Management
Texas
$1.09M -$183K -3,400 -12%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$1.07M +$27K +500 +2%
CCM
41
Cadence Capital Management
Massachusetts
$913K +$557K +10,313 +97%
TAM
42
Tocqueville Asset Management
New York
$871K – – –
GA
43
Geneva Advisors
Illinois
$866K -$440K -8,155 -29%
Wellington Management Group
44
Wellington Management Group
Massachusetts
$823K +$764K +14,163 +298%
BIM
45
BlackRock Investment Management
Delaware
$746K -$19.9K -369 -2%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$730K – – –
NA
47
Navellier & Associates
Nevada
$610K +$238K +4,414 +46%
ACM
48
Ativo Capital Management
Illinois
$593K +$5.4K +100 +0.9%
Asset Management One
49
Asset Management One
Japan
$408K +$297K +5,504 +142%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$392K – – –
1
2
3 4

BSTC Hedge Fund Activity: Q3 2015 in Review

86 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2015, worth a combined $148M — down 3.2% from $152M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BSTC positions and 8 closed out — a net gain of 3 holders — while 42 added to existing stakes and 21 trimmed.

The largest buyer was Allianz Asset Management, adding an estimated $5.28M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.42M sold.

  • 86 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2015, up from 83 in Q2 2015.
  • Funds reported $148M of BioSpecifics Technologies Corp. stock for Q3 2015, down 3.2% quarter-over-quarter.
  • 11 funds opened new BioSpecifics Technologies Corp. positions in Q3 2015 and 8 closed out, a net change of +3 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2015 was Allianz Asset Management, an estimated $5.28M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2015 was Franklin Resources, an estimated $7.42M sold.

Based on aggregated 13F filings for Q3 2015.